Qube Research & Technologies LTD Fulcrum Therapeutics, Inc. Transaction History
Qube Research & Technologies LTD
- $61.9 Billion
- Q1 2024
A detailed history of Qube Research & Technologies LTD transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 723,163 shares of FULC stock, worth $5.79 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
723,163
Previous 242,908
197.71%
Holding current value
$5.79 Million
Previous $1.64 Million
316.47%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding FULC
# of Institutions
136Shares Held
44.2MCall Options Held
3.12MPut Options Held
128K-
Rtw Investments, LP New York, NY5.85MShares$46.8 Million0.89% of portfolio
-
Cowen And Company, LLC3.71MShares$29.7 Million1.18% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.85MShares$22.8 Million1.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$20.3 Million0.0% of portfolio
-
Trv Gp Iv, LLC Boston, MA2.34MShares$18.7 Million10.72% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $416M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...